The first rapid prototyping therapeutics company
Unravel Biosciences has raised $550K in total funding. The most recent round was Grant. The last funding was announced in March 2023.
Unravel Biosciences's investors include Creative Destruction Lab, KdT Ventures, Massachusetts General Hospital, Good Ventures, BoxOne Ventures.
Unravel Biosciences is headquartered in Boston, United States.
The first rapid prototyping therapeutics company
Unravel Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Unravel Biosciences — Funding & Investors." VCBacked, March 29, 2023, https://www.vcbacked.co/company/unravel-biosciences. Accessed August 14, 2026.
VCBacked. (2023). Unravel Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/unravel-biosciences
{{cite web |title=Unravel Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/unravel-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated